AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

BFR Training and Knee Osteoarthritis

RecruitingNAAges 40 Years - 70 YearsAllUniversity of Hail
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Knee osteoarthritis (KOA) is a chronic, progressive degenerative joint disease characterized by cartilage and bone degeneration, synovial inflammation, and structural changes. Clinically, it presents with pain, morning stiffness, swelling, crepitus, and limited range of motion, leading to functional impairment, gait abnormalities, and reduced quality of life. Globally, KOA affects \~302 million people. In Saudi Arabia, prevalence rises from 30.8% (ages 46-55) to \>60% (ages 66-75), with higher rates in older, female, and obese individuals. Key risk factors include aging, female sex, obesity, prior knee injury, and genetics. The condition imposes significant health burdens and socioeconomic costs. The International Classification of Functioning, Disability, and Health (ICF) identifies KOA as a major cause of physical disability. Pain, restricted motion, and muscle weakness drive quality-

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Male and female Age โ‰ฅ 40years. * Clinical and radiographic diagnosis of unilateral knee osteoarthritis KOA (Kellgren-Lawrence grade 2, or 3). * Willing to attend 3 supervised sessions/week for 8 weeks. * Able to provide informed consent. Exclusion Criteria: * Peripheral vascular disease, active cancer, lower limb infection, open wound * history of intra-articular injections within the last 3 months * medical condition that may affect their ability to perform exercise (uncontrolled cardiovascular, or neurological disorders) * cognitive and psychiatric disorders
๐Ÿ’Š

What it tests

  • Standard Treatment
  • Pain neuroscience education
  • Blood flow restriction training
๐Ÿ“

Where

1 site
University of Hail
Ha'il, Saudi Arabia
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy